Get started
Author

Fanfeng Bu

Observed name: F. Bu
OpenAlex ID: A5089674189
Molecular characteristics of EGFR exon 19 deletion subtypes in NSCLC patients.
2021 · Weiquan Gu, Zhongyu Lu, et al. · Journal of Clinical Oncology · 4
Molecular characteristics of ERBB2-activating mutations in Chinese patients with NSCLC.
2022 · Fan Xu, Qingshan Li, et al. · Journal of Clinical Oncology · 3
The analysis of EGFR variants in Chinese adult glioblastoma patients.
2021 · Qiao Li, Weijie Sun, et al. · Journal of Clinical Oncology · 3
Correlation between PD-L1 high-expression and EGFR variants in non-small cell lung cancer.
2022 · Yifei Liu, Fei Quan, et al. · Journal of Clinical Oncology · 2
A Novel Germline SDHA Gene Mutation and Co-Occurring Somatic KIT Activating Mutation in a Patient With Pediatric Central Nervous System Germ Cell Tumor: Case Report
2022 · Xizan Yue, Bo Liu, et al. · Frontiers in Oncology · 2
PDF
AKT1 in Asia: A landscape analysis of 11,813 Chinese tumor samples.
2021 · PingPing Gan, Yi Lu, et al. · Journal of Clinical Oncology · 2
217P Clinical and molecular features of PTCH1 mutant in solid tumors
2023 · X. Li, T. Han, et al. · Annals of Oncology · 1
PDF
Analysis of ATM germline mutations in solid tumors from Chinese patients.
2023 · Tao Fu, Yaping Zhao, et al. · Journal of Clinical Oncology · 1
The analysis of BRAF fusions characteristics in Chinese solid tumor patients.
2023 · Fang Ma, Yaping Zhao, et al. · Journal of Clinical Oncology · 1
Mutational landscape of intracranial germ cell tumors.
2023 · Jiangong Wang, Tiantian Han, et al. · Journal of Clinical Oncology · 1
PDF
Prevalence and characteristics analysis of CDKN2A/B deletion in glioma.
2023 · Dongxiao Zhuang, Tiantian Han, et al. · Journal of Clinical Oncology · 1
PDF
Molecular profile of SWI/SNF complex in Chinese patients with ovarian cancer.
2023 · Jianmin Li, Tiantian Han, et al. · Journal of Clinical Oncology · 1
Diverse genomic characterization of Chinese patients with osteosarcoma and soft tissue sarcoma.
2023 · Mengxiong Sun, Fei Quan, et al. · Journal of Clinical Oncology · 1
PDF
1014P Resistance landscape to almonertinib in EGFR-mutated NSCLC
2022 · M. Tian, Z. Lu, et al. · Annals of Oncology · 1
PDF
Analysis of MET genetic aberrations in Chinese solid tumor patients.
2022 · Guanglong Huang, Zhengying Bian, et al. · Journal of Clinical Oncology · 1
NGS analysis of germline mutation profile of patients with hepatocellular carcinoma in China.
2022 · Xiaobing Wu, Didi Guo, et al. · Journal of Clinical Oncology · 1
The analysis of BRAF fusions in Chinese patients with glioma.
2022 · Chuandong Cheng, Ying Ji, et al. · Journal of Clinical Oncology · 1
365P The analysis of FGFR-gene family alterations in glioma
2021 · Y. Li, T. Han, et al. · Annals of Oncology · 1
113P The analysis of EGFR fusions characteristics in Chinese solid tumor patients
2021 · G. Mao, J. Ma, et al. · Annals of Oncology · 1
Comparison of next-generation sequencing and FISH/IHC for molecular classification in glioma.
2021 · Deze Jia, Yi Lu, et al. · Journal of Clinical Oncology · 1
MAPK pathway alteration may be a new integrated diagnosis term.
2021 · Chuandong Cheng, Ying Ji, et al. · Journal of Clinical Oncology · 1
209P Molecular atlas of copy number variation(CNV) in lung cancer with brain metastases
2023 · X. Zhang, T. Han, et al. · Annals of Oncology
PDF
544P Clinical and molecular features of primary central nervous system tumor with Lynch syndrome
2023 · N. Liu, R. Kong, et al. · Annals of Oncology
PDF
520P Copy number variation spectrum analysis of primary glioblastoma
2023 · C. Cheng, Y. Ji, et al. · Annals of Oncology
PDF
519P The landscape of PDGFRA mutation in Chinese patients with glioma
2023 · Q. Lv, T. Han, et al. · Annals of Oncology
PDF
Works count: 46
Citation count: 31
H-index: 3
I10-index:
Year
Topic
Type